$Organogenesis (ORGO.US)$ revenue of $110.0 million for the ...
$Organogenesis(ORGO.US$ revenue of $110.0 million for the first quarter of 2024, an increase
of $2.3 million compared to net revenue of $107.6 million for the first
quarter of 2023. Net revenue for the first quarter of 2024 consists of:
-- Net revenue from Advanced Wound Care products of $103.9 million,
an increase of 3% from the first quarter of 2023.
-- Net revenue from Surgical & Sports Medicine products of $6.1
million, a decrease of 9% from the first quarter of 2023.
-- Net loss of $2.1 million for the first quarter of 2024, compared to a net
loss of $3.0 million for the first quarter of 2023, a decrease in net
loss of $0.9 million.
-- Adjusted net loss1 of $1.4 million for the first quarter of 2024,
compared to an adjusted net loss of $0.7 million for the first quarter of
2023, an increase in adjusted net loss of $0.8 million.
-- Adjusted EBITDA of $2.6 million for the first quarter of 2024, compared
to Adjusted EBITDA of $3.8 million for the first quarter of 2023, a
decrease of $1.2 million.
of $2.3 million compared to net revenue of $107.6 million for the first
quarter of 2023. Net revenue for the first quarter of 2024 consists of:
-- Net revenue from Advanced Wound Care products of $103.9 million,
an increase of 3% from the first quarter of 2023.
-- Net revenue from Surgical & Sports Medicine products of $6.1
million, a decrease of 9% from the first quarter of 2023.
-- Net loss of $2.1 million for the first quarter of 2024, compared to a net
loss of $3.0 million for the first quarter of 2023, a decrease in net
loss of $0.9 million.
-- Adjusted net loss1 of $1.4 million for the first quarter of 2024,
compared to an adjusted net loss of $0.7 million for the first quarter of
2023, an increase in adjusted net loss of $0.8 million.
-- Adjusted EBITDA of $2.6 million for the first quarter of 2024, compared
to Adjusted EBITDA of $3.8 million for the first quarter of 2023, a
decrease of $1.2 million.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
